|
ZCCHC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.951500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.775800E-02 |
| Normal-vs-Stage2 |
6.926000E-01 |
| Normal-vs-Stage3 |
1.455360E-01 |
| Normal-vs-Stage4 |
8.757200E-01 |
| Stage1-vs-Stage2 |
5.614300E-02 |
| Stage1-vs-Stage3 |
4.829400E-01 |
| Stage1-vs-Stage4 |
5.169000E-01 |
| Stage2-vs-Stage3 |
1.106620E-01 |
| Stage2-vs-Stage4 |
6.861000E-01 |
| Stage3-vs-Stage4 |
2.414200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.111500E-02 |
| Normal-vs-AfricanAmerican |
2.513400E-01 |
| Normal-vs-Asian |
3.873800E-01 |
| Caucasian-vs-AfricanAmerican |
4.586200E-01 |
| Caucasian-vs-Asian |
7.350000E-01 |
| AfricanAmerican-vs-Asian |
5.024400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.546100E-02 |
| Normal-vs-Female |
9.881700E-02 |
| Male-vs-Female |
6.813200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.100400E-01 |
| Normal-vs-Extreme_Weight |
2.235600E-01 |
| Normal-vs-Obese |
3.847800E-02 |
| Normal-vs-Extreme_Obese |
7.603800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.807000E-01 |
| Normal_Weight-vs-Obese |
6.295400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.172800E-01 |
| Extreme_Weight-vs-Obese |
3.758400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.178000E-01 |
| Obese-vs-Extreme_Obese |
4.052200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.321500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.763500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.461000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.472200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.032600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.783360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.974200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.915730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.574100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.746600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.961400E-03 |
| Normal-VS-Type2 PRCC |
4.492400E-01 |
| Normal-VS-KIRP CIMP |
1.564580E-01 |
| Normal-VS-Unclassified PRCC |
6.295700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.155840E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.842200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.201000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.948000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.772000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.592130E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.993000E-01 |
| Normal-vs-N1 |
6.373500E-02 |
| Normal-vs-N2 |
1.757230E-01 |
| N0-vs-N1 |
7.338400E-02 |
| N0-vs-N2 |
4.069800E-01 |
| N1-vs-N2 |
1.816810E-01 |
|
|
